Ken Moir, VP marketing director at NiceLabel explains why labelling is an unassuming challenge for pharma manufacturers wanting to keep up with regulatory compliance.
Centralised
The pharmaceutical industry arguably faces more challenges than most other industries. Regulatory compliance is part and parcel of working in the sector, but, in a business where bringing a drug to market carries such a large investment, cost pressures, particularly when a drug comes off patent, are perhaps higher than other industries.
Therefore, finding the balance between complying to regulation, driving efficiencies in the manufacturing process and maintaining quality can mean the difference between being competitive or not.